این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 28 آذر 1404
Iranian Journal of Kidney Diseases
، جلد ۸، شماره ۵، صفحات ۴۰۸-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Effects of Pioglitazone on Blood Glucose and Inflammatory Markers of Diabetic Kidney Transplant Patients: a Randomized Controlled Trial
چکیده انگلیسی مقاله
Introduction. The aim of this study was to assess the effects of pioglitazone on blood glucose control and inflammatory biomarkers in diabetic patients receiving insulin after kidney transplantation. Materials and Methods. In a randomized placebo-controlled trial, 62 diabetic kidney transplant patients were followed for 4 months after randomly assigned to placebo and pioglitazone (30 mg/d) groups. All of the patients continued their insulin therapy irrespective of the group that they were assigned to, in order to evaluate the effects of addition of pioglitazone on blood glucose and inflammation biomarkers including serum C-reactive protein, high-sensitivity C-reactive protein, and interleukin-18 levels, as well as erythrocyte sedimentation rate. Results. At baseline, there were no significant differences in laboratory studies between the two groups. After 4 months of intervention, along with significant improvement in hemoglobin A1c in the pioglitazone group, daily insulin requirements also decreased and lipid profile improved significantly. In addition, erythrocyte sedimentation rate, C-reactive protein, and high-sensitivity C-reactive protein values were significantly lower in the pioglitazone group ( P = .03, P < .001, and P = .01). Interleukin-18 levels were not significantly different at the end of the study between the two groups, but it had a decreasing trend in the pioglitazone group ( P = .002). Conclusions. Pioglitazone complementing insulin in diabetic kidney transplant patients not only improved glycemic control, evidenced by hemoglobin A1c, and reduced daily insulin requirement, but also decreased inflammatory markers which may have an impact on overall cardiovascular events and mortalities beyond glycemic control.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
علی خوارزم کیا | ali kharazmkia
پدرام احمدپور | pedram ahmadpoor
شادی ضیایی | shadi ziaei
جمشید سلام زاده | jamshid salamzadeh
فاطمه پور رضا قلی | fatemeh pour reza gholi
علیرضا خوشدل | alireza khoshdel
شیوا سماوات | shiva samavat
فریبا صمدیان | fariba samadian
محسن نفر | mohsen nafar
نشانی اینترنتی
http://www.ijkd.org/index.php/ijkd/article/view/1317
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
ORIGINAL | Transplantation
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات